tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

COLL Stock Latest News

Collegium Pharmaceutical Approves 2025 Equity Incentive Plan
Company AnnouncementsCollegium Pharmaceutical Approves 2025 Equity Incentive Plan
1M ago
8K
COLL
Collegium Pharmaceutical announces $25M accelerated share repurchase program
PremiumThe Fly
Collegium Pharmaceutical announces $25M accelerated share repurchase program
2M ago
COLL
Collegium Pharmaceutical Announces Share Repurchase Agreement
PremiumCompany Announcements
Collegium Pharmaceutical Announces Share Repurchase Agreement
2M ago
8K
COLL
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives
PremiumCompany Announcements
Collegium Pharmaceutical’s Earnings Call Highlights Growth and Strategic Initiatives
2M ago
COLL
Collegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
PremiumThe Fly
Collegium Pharmaceutical price target raised to $37 from $36 at Piper Sandler
2M ago
COLL
Strong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
PremiumRatingsStrong Buy Rating for Collegium Pharmaceutical Driven by Robust 2025 Performance and Growth Potential
2M ago
COLL
Collegium Pharmaceutical Reports Strong Q1 2025 Growth
Premium
Company Announcements
Collegium Pharmaceutical Reports Strong Q1 2025 Growth
2M ago
COLL
Collegium Pharmaceutical Reports 23% Revenue Increase
Premium
Company Announcements
Collegium Pharmaceutical Reports 23% Revenue Increase
2M ago
8K
COLL
Collegium Pharmaceutical reports Q1 adjusted EPS $1.49, consensus $1.45
PremiumThe Fly
Collegium Pharmaceutical reports Q1 adjusted EPS $1.49, consensus $1.45
2M ago
COLL
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $742.47M
PremiumThe Fly
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $742.47M
2M ago
COLL
Is COLL a Buy, Before Earnings?
PremiumPre-Earnings
Is COLL a Buy, Before Earnings?
2M ago
COLL
Buy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
PremiumRatings
Buy Recommendation for Collegium Pharmaceutical Driven by Stability and Growth Potential
3M ago
COLL
Collegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
PremiumRatingsCollegium Pharmaceutical: Undervalued Stock with Strong Growth Potential and Low Risk
3M ago
COLL
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning
Premium
Ratings
Glen Santangelo Reiterates Buy Rating on Collegium Pharmaceutical, Citing Undervalued Pain Portfolio and Strong Market Positioning
4M ago
COLL
Collegium Pharmaceutical Appoints New Executive VP and General Counsel
Premium
Company Announcements
Collegium Pharmaceutical Appoints New Executive VP and General Counsel
4M ago
8K
COLL
Collegium announces updates to its board of directors, executive team
PremiumThe Fly
Collegium announces updates to its board of directors, executive team
4M ago
COLL
Collegium Pharma’s Earnings Call Highlights Growth and Strategy
PremiumCompany Announcements
Collegium Pharma’s Earnings Call Highlights Growth and Strategy
4M ago
COLL
Positive Outlook for Collegium Pharmaceutical: Strong Performance and Strategic Growth Initiatives Support Buy Rating
PremiumRatings
Positive Outlook for Collegium Pharmaceutical: Strong Performance and Strategic Growth Initiatives Support Buy Rating
4M ago
COLL
Collegium Pharmaceutical Reports Record 2024 Financial Results
PremiumCompany Announcements
Collegium Pharmaceutical Reports Record 2024 Financial Results
4M ago
COLL
Collegium Pharmaceutical Reports Record 2024 Financial Results
PremiumCompany AnnouncementsCollegium Pharmaceutical Reports Record 2024 Financial Results
4M ago
8K
COLL
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $740.44M
Premium
The Fly
Collegium Pharmaceutical backs FY25 revenue view $735M-$750M, consensus $740.44M
4M ago
COLL
Collegium Pharmaceutical reports Q4 adjusted EPS $1.77, consensus $1.54
Premium
The Fly
Collegium Pharmaceutical reports Q4 adjusted EPS $1.77, consensus $1.54
4M ago
COLL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >